Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 01
2021
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,318
+16.59%
|
-
|
|
Jan 01
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
44,291
-2.14%
|
$1,550,185
$35.95 P/Share
|
|
Jan 01
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
108,797
+5.0%
|
-
|
|
Jan 01
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,127
-8.03%
|
$74,445
$35.95 P/Share
|
|
Jan 01
2021
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,527
+19.78%
|
-
|
|
Jan 01
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
3,859
-2.69%
|
$135,065
$35.95 P/Share
|
|
Jan 01
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
11,967
+7.69%
|
-
|
|
Jan 01
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
5,001
-29.45%
|
$175,035
$35.95 P/Share
|
|
Jan 01
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
16,318
+49.01%
|
-
|
|
Jan 01
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
3,625
-1.52%
|
$126,875
$35.95 P/Share
|
|
Jan 01
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
9,791
+3.94%
|
-
|
|
Jan 01
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,127
-8.16%
|
$74,445
$35.95 P/Share
|
|
Jan 01
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,527
+20.03%
|
-
|
|
Jan 01
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,360
-5.22%
|
$82,600
$35.95 P/Share
|
|
Jan 01
2021
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,071
+13.52%
|
-
|
|
Jan 01
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
5,891
-5.74%
|
$206,185
$35.95 P/Share
|
|
Jan 01
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
10,879
+9.58%
|
-
|
|
Dec 17
2020
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Bona fide gift
|
Direct |
150
-0.11%
|
-
|
|
Dec 11
2020
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Bona fide gift
|
Direct |
50
-0.04%
|
-
|
|
Dec 03
2020
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
296
-0.22%
|
$9,768
$33.81 P/Share
|
|
Dec 03
2020
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
649
+0.49%
|
-
|
|
Dec 01
2020
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
46,584
-26.16%
|
$1,537,272
$33.53 P/Share
|
|
Dec 01
2020
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
46,584
+20.74%
|
$326,088
$7.16 P/Share
|
|
Dec 01
2020
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,383
-14.76%
|
$111,639
$33.65 P/Share
|
|
Dec 01
2020
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
11,472
+33.35%
|
-
|
|
Dec 01
2020
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
733
-5.81%
|
$24,189
$33.65 P/Share
|
|
Dec 01
2020
|
Scott Olson SVP & Pres, CRM, Diagnostics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,485
+10.53%
|
-
|
|
Nov 09
2020
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
2,028
-75.39%
|
$79,092
$39.0 P/Share
|
|
Nov 03
2020
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
259,207
-11.68%
|
$9,072,245
$35.06 P/Share
|
|
Oct 01
2020
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
2,282
-45.9%
|
$86,716
$38.56 P/Share
|
|
Oct 01
2020
|
Stephen P Macmillan Director |
BUY
Grant, award, or other acquisition
|
Direct |
498
+5.86%
|
-
|
|
Aug 28
2020
|
Wendy Carruthers EVP, Human Resources |
SELL
Bona fide gift
|
Direct |
2,657
-1.48%
|
-
|